Alkermes plc. Logo

Alkermes plc.

Develops and commercializes medicines for central nervous system (CNS) diseases.

ALKS | US

Overview

Corporate Details

ISIN(s):
IE00B56GVS15 (+1 more)
LEI:
Country:
United States of America
Address:
CONNAUGHT HOUSE, 0 DUBLIN 4

Description

Alkermes plc is a global biopharmaceutical company that develops and commercializes medicines for diseases of the central nervous system (CNS). The company's research and development efforts focus on complex psychiatric and neurological disorders. Its portfolio includes treatments for conditions such as schizophrenia, bipolar I disorder, alcohol dependence, and opioid dependence. Alkermes' clinical-stage pipeline features investigational therapies, including orexin 2 receptor agonists for sleep disorders like narcolepsy and idiopathic hypersomnia. The company's commercialized products include olanzapine and samidorphan, an oral atypical antipsychotic drug for adults with schizophrenia or bipolar I disorder.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-09 01:38 English ZIP 7.2 KB
2026-01-08 23:23
PRIMARY DOCUMENT
English ZIP 7.6 KB
2026-01-06 13:06
8-K
English ZIP 70.8 KB
2026-01-02 22:39
PRIMARY DOCUMENT
English ZIP 6.7 KB
2026-01-02 22:36 English ZIP 7.3 KB
2025-12-05 22:21
PRIMARY DOCUMENT
English ZIP 7.6 KB
2025-12-03 22:32 English ZIP 7.2 KB
2025-12-01 23:41
PRIMARY DOCUMENT
English ZIP 6.7 KB
2025-12-01 22:45 English ZIP 7.2 KB
2025-11-19 12:28
8-K
English ZIP 869.1 KB
2025-11-12 14:45
8-K
English ZIP 7.0 MB
2025-11-03 22:37
PRIMARY DOCUMENT
English ZIP 7.6 KB
2025-11-03 22:35 English ZIP 7.3 KB
2025-10-28 14:20
10-Q
English ZIP 3.4 MB
2025-10-28 12:05
8-K
English ZIP 5.0 MB

Automate Your Workflow. Get a real-time feed of all Alkermes plc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alkermes plc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alkermes plc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT
Arcus Biosciences, Inc. Logo
A clinical-stage biopharmaceutical company developing combination therapies for cancer.
United States of America
RCUS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.